Compare GAUZ & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GAUZ | SENS |
|---|---|---|
| Founded | 2009 | 1996 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Industrial Machinery/Components |
| Sector | Miscellaneous | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5M | 301.2M |
| IPO Year | 2019 | 2014 |
| Metric | GAUZ | SENS |
|---|---|---|
| Price | $0.71 | $6.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $11.50 | ★ $18.38 |
| AVG Volume (30 Days) | 605.5K | ★ 1.2M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,389,000.00 |
| Revenue This Year | $22.59 | $74.15 |
| Revenue Next Year | $59.03 | $58.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.85 |
| 52 Week Low | $0.37 | $0.41 |
| 52 Week High | $9.60 | $8.75 |
| Indicator | GAUZ | SENS |
|---|---|---|
| Relative Strength Index (RSI) | 49.45 | 61.22 |
| Support Level | $0.44 | $6.62 |
| Resistance Level | $0.94 | $6.87 |
| Average True Range (ATR) | 0.19 | 0.42 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 40.23 | 100.00 |
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.